(PCTY) Paylocity Holdng - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US70438V1061
Payroll, Hr, Time, Talent, Benefits
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 33.6% |
| Value at Risk 5%th | 51.9% |
| Relative Tail Risk | -5.96% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.01 |
| Alpha | -38.76 |
| CAGR/Max DD | -0.21 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.359 |
| Beta | 0.845 |
| Beta Downside | 0.839 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.39% |
| Mean DD | 23.18% |
| Median DD | 23.50% |
Description: PCTY Paylocity Holdng November 03, 2025
Paylocity Holding Corp. (NASDAQ:PCTY) delivers a cloud-based suite of Human Capital Management (HCM) tools-including payroll, tax, benefits, time-and-attendance, talent acquisition, and finance-focused modules-targeting U.S. employers across a broad range of industries such as healthcare, retail, and technology. The platform is sold primarily through a direct sales force and is supported by implementation, training, and regulatory services.
In FY 2023 the company reported revenue of roughly $1.1 billion, a year-over-year increase of about 15%, and a subscription-based annual recurring revenue (ARR) run-rate exceeding $1.2 billion with a gross margin near 80%. Paylocity’s churn rate has stayed under 5% for the past two years, reflecting strong customer stickiness, while its backlog-approximately $2.5 billion-provides visibility into future sales. Macro-level drivers include the continued shift of midsize firms toward SaaS payroll solutions and a tight labor market that fuels demand for integrated talent and workforce analytics.
For a deeper quantitative dive and scenario analysis, you may find the ValueRay platform’s data visualizations useful for assessing Paylocity’s valuation dynamics.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (225.5m TTM) > 0 and > 6% of Revenue (6% = 98.4m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 0.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -155.9% (prev 56.72%; Δ -212.7pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 413.2m > Net Income 225.5m (YES >=105%, WARN >=100%) |
| Net Debt (-37.7m) to EBITDA (420.3m) ratio: -0.09 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (55.9m) change vs 12m ago -0.72% (target <= -2.0% for YES) |
| Gross Margin 68.81% (prev 68.50%; Δ 0.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 39.72% (prev 34.85%; Δ 4.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1060 (EBITDA TTM 420.3m / Interest Expense TTM -297.0k) >= 6 (WARN >= 3) |
Altman Z'' -2.40
| (A) -0.60 = (Total Current Assets 387.4m - Total Current Liabilities 2.95b) / Total Assets 4.24b |
| (B) 0.22 = Retained Earnings (Balance) 948.6m / Total Assets 4.24b |
| (C) 0.08 = EBIT TTM 314.8m / Avg Total Assets 4.13b |
| (D) 0.30 = Book Value of Equity 954.9m / Total Liabilities 3.13b |
| Total Rating: -2.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.88
| 1. Piotroski 5.50pt |
| 2. FCF Yield 4.81% |
| 3. FCF Margin 23.28% |
| 4. Debt/Equity 0.12 |
| 5. Debt/Ebitda -0.09 |
| 6. ROIC - WACC (= 5.59)% |
| 7. RoE 19.12% |
| 8. Rev. Trend 89.63% |
| 9. EPS Trend 77.10% |
What is the price of PCTY shares?
As of December 14, 2025, the stock is trading at USD 150.89 with a total of 612,618 shares traded.
Over the past week, the price has changed by +2.98%, over one month by +1.96%, over three months by -11.07% and over the past year by -26.25%.
Over the past week, the price has changed by +2.98%, over one month by +1.96%, over three months by -11.07% and over the past year by -26.25%.
Is PCTY a buy, sell or hold?
Paylocity Holdng has received a consensus analysts rating of 4.15.
Therefore, it is recommended to buy PCTY.
- Strong Buy: 10
- Buy: 4
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the PCTY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 194.2 | 28.7% |
| Analysts Target Price | 194.2 | 28.7% |
| ValueRay Target Price | 138.6 | -8.1% |
PCTY Fundamental Data Overview December 03, 2025
Market Cap USD = 7.98b (7.98b USD * 1.0 USD.USD)
P/E Trailing = 36.7945
P/E Forward = 24.6914
P/S = 4.8669
P/B = 7.238
P/EG = 1.5283
Beta = 0.582
Revenue TTM = 1.64b USD
EBIT TTM = 314.8m USD
EBITDA TTM = 420.3m USD
Long Term Debt = 81.2m USD (from longTermDebt, last quarter)
Short Term Debt = 8.62m USD (from shortTermDebt, last fiscal year)
Debt = 127.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -37.7m USD (from netDebt column, last quarter)
Enterprise Value = 7.95b USD (7.98b + Debt 127.5m - CCE 165.2m)
Interest Coverage Ratio = -1060 (Ebit TTM 314.8m / Interest Expense TTM -297.0k)
FCF Yield = 4.81% (FCF TTM 381.8m / Enterprise Value 7.95b)
FCF Margin = 23.28% (FCF TTM 381.8m / Revenue TTM 1.64b)
Net Margin = 13.75% (Net Income TTM 225.5m / Revenue TTM 1.64b)
Gross Margin = 68.81% ((Revenue TTM 1.64b - Cost of Revenue TTM 511.6m) / Revenue TTM)
Gross Margin QoQ = 68.55% (prev 67.84%)
Tobins Q-Ratio = 1.88 (Enterprise Value 7.95b / Total Assets 4.24b)
Interest Expense / Debt = 0.76% (Interest Expense 971.0k / Debt 127.5m)
Taxrate = 35.94% (26.9m / 74.9m)
NOPAT = 201.7m (EBIT 314.8m * (1 - 35.94%))
Current Ratio = 0.13 (Total Current Assets 387.4m / Total Current Liabilities 2.95b)
Debt / Equity = 0.12 (Debt 127.5m / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = -0.09 (Net Debt -37.7m / EBITDA 420.3m)
Debt / FCF = -0.10 (Net Debt -37.7m / FCF TTM 381.8m)
Total Stockholder Equity = 1.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.32% (Net Income 225.5m / Total Assets 4.24b)
RoE = 19.12% (Net Income TTM 225.5m / Total Stockholder Equity 1.18b)
RoCE = 24.97% (EBIT 314.8m / Capital Employed (Equity 1.18b + L.T.Debt 81.2m))
RoIC = 14.59% (NOPAT 201.7m / Invested Capital 1.38b)
WACC = 8.99% (E(7.98b)/V(8.11b) * Re(9.13%) + D(127.5m)/V(8.11b) * Rd(0.76%) * (1-Tc(0.36)))
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.88%
[DCF Debug] Terminal Value 77.99% ; FCFE base≈369.3m ; Y1≈455.6m ; Y5≈777.3m
Fair Price DCF = 198.9 (DCF Value 10.82b / Shares Outstanding 54.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 77.10 | EPS CAGR: 30.77% | SUE: 2.77 | # QB: 16
Revenue Correlation: 89.63 | Revenue CAGR: 21.60% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.50 | Chg30d=-0.031 | Revisions Net=-8 | Analysts=19
EPS current Year (2026-06-30): EPS=7.43 | Chg30d=+0.140 | Revisions Net=+6 | Growth EPS=+3.7% | Growth Revenue=+8.1%
EPS next Year (2027-06-30): EPS=8.14 | Chg30d=+0.175 | Revisions Net=+3 | Growth EPS=+9.5% | Growth Revenue=+8.7%
P/E Trailing = 36.7945
P/E Forward = 24.6914
P/S = 4.8669
P/B = 7.238
P/EG = 1.5283
Beta = 0.582
Revenue TTM = 1.64b USD
EBIT TTM = 314.8m USD
EBITDA TTM = 420.3m USD
Long Term Debt = 81.2m USD (from longTermDebt, last quarter)
Short Term Debt = 8.62m USD (from shortTermDebt, last fiscal year)
Debt = 127.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -37.7m USD (from netDebt column, last quarter)
Enterprise Value = 7.95b USD (7.98b + Debt 127.5m - CCE 165.2m)
Interest Coverage Ratio = -1060 (Ebit TTM 314.8m / Interest Expense TTM -297.0k)
FCF Yield = 4.81% (FCF TTM 381.8m / Enterprise Value 7.95b)
FCF Margin = 23.28% (FCF TTM 381.8m / Revenue TTM 1.64b)
Net Margin = 13.75% (Net Income TTM 225.5m / Revenue TTM 1.64b)
Gross Margin = 68.81% ((Revenue TTM 1.64b - Cost of Revenue TTM 511.6m) / Revenue TTM)
Gross Margin QoQ = 68.55% (prev 67.84%)
Tobins Q-Ratio = 1.88 (Enterprise Value 7.95b / Total Assets 4.24b)
Interest Expense / Debt = 0.76% (Interest Expense 971.0k / Debt 127.5m)
Taxrate = 35.94% (26.9m / 74.9m)
NOPAT = 201.7m (EBIT 314.8m * (1 - 35.94%))
Current Ratio = 0.13 (Total Current Assets 387.4m / Total Current Liabilities 2.95b)
Debt / Equity = 0.12 (Debt 127.5m / totalStockholderEquity, last quarter 1.10b)
Debt / EBITDA = -0.09 (Net Debt -37.7m / EBITDA 420.3m)
Debt / FCF = -0.10 (Net Debt -37.7m / FCF TTM 381.8m)
Total Stockholder Equity = 1.18b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.32% (Net Income 225.5m / Total Assets 4.24b)
RoE = 19.12% (Net Income TTM 225.5m / Total Stockholder Equity 1.18b)
RoCE = 24.97% (EBIT 314.8m / Capital Employed (Equity 1.18b + L.T.Debt 81.2m))
RoIC = 14.59% (NOPAT 201.7m / Invested Capital 1.38b)
WACC = 8.99% (E(7.98b)/V(8.11b) * Re(9.13%) + D(127.5m)/V(8.11b) * Rd(0.76%) * (1-Tc(0.36)))
Discount Rate = 9.13% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.88%
[DCF Debug] Terminal Value 77.99% ; FCFE base≈369.3m ; Y1≈455.6m ; Y5≈777.3m
Fair Price DCF = 198.9 (DCF Value 10.82b / Shares Outstanding 54.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 77.10 | EPS CAGR: 30.77% | SUE: 2.77 | # QB: 16
Revenue Correlation: 89.63 | Revenue CAGR: 21.60% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.50 | Chg30d=-0.031 | Revisions Net=-8 | Analysts=19
EPS current Year (2026-06-30): EPS=7.43 | Chg30d=+0.140 | Revisions Net=+6 | Growth EPS=+3.7% | Growth Revenue=+8.1%
EPS next Year (2027-06-30): EPS=8.14 | Chg30d=+0.175 | Revisions Net=+3 | Growth EPS=+9.5% | Growth Revenue=+8.7%
Additional Sources for PCTY Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle